Delivery Order SPE2DB22D2218-SPE2DB25FR3FA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $150,882.31 to AmerisourceBergen Drug Corp on October 20, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is set for completion by October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. The award falls...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,738.16 to AmerisourceBergen Drug Corp on September 19, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.9 million through December 2026. The contract was competitively awarded with no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, with completion scheduled for the same date. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $387,190.90 to AmerisourceBergen Drug Corp on July 28, 2025, under a firm fixed-price contract type. The contract, which is a child order under AmerisourceBergen's larger Pharmaceutical Prime Vendor Global Program IDC, is scheduled for completion by July 29, 2025. No set-aside designation was used in this competitive award, and performance will take place at AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $20,895.86 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract employs a firm fixed-price model with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $55,543.32 to AmerisourceBergen Drug Corp on August 4, 2025, under a firm fixed-price contract with an ultimate completion date of August 5, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp, the nation's largest pharmaceutical distributor, on July 10, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, which carries a $999.99 billion ceiling value through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order valued at $3,731.87 to AmerisourceBergen Drug Corp on October 27, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, with performance in Conshohocken, Pennsylvania, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a $50,396.40 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3FADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,418.74 to AmerisourceBergen Drug Corp on August 21, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a major pharmaceutical prime vendor for DLA, AmerisourceBergen demonstrates significant capacity to fulfill federal medical supply requirements on a global scale. The company's prime indefinite delivery contract functions as a comprehensive pharmaceutical support vehicle enabling supply of critical medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen among key strategic vendors for federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 8/21/25 |